New York Times Company v. Defense Health Agency

CourtDistrict Court, District of Columbia
DecidedApril 25, 2021
DocketCivil Action No. 2021-0566
StatusPublished

This text of New York Times Company v. Defense Health Agency (New York Times Company v. Defense Health Agency) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
New York Times Company v. Defense Health Agency, (D.D.C. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

THE NEW YORK TIMES COMPANY,

Plaintiff, Civil Action No. 21-cv-566 (BAH) v. Chief Judge Beryl A. Howell DEFENSE HEALTH AGENCY and DEPARTMENT OF HEALTH AND HUMAN SERVICES,

Defendants.

MEMORANDUM OPINION

Plaintiff, The New York Times Company (“NYT”), seeks a preliminary injunction to

compel defendants, the Defense Health Agency (“DHA”), a component of the United States

Department of Defense, Compl. ¶ 3, ECF No. 1, and the United States Department of Health and

Human Services (“HHS”), to respond and produce, on an expedited basis and by a date certain

“20 business days of the Court’s order,” all non-exempt records responsive to plaintiff’s

December 24, 2020 requests, pursuant to the Freedom of Information Act (“FOIA”), 5 U.S.C. §

552, for extensive data regarding the federal government’s nationwide effort to distribute

coronavirus vaccines to the American public, Pl.’s Mot. Preliminary Injunction (“Pl.’s Mot.”) at

1–2, ECF No. 8; Compl. ¶¶ 8, 16–17. 1 Defendants object that this request for extraordinary

injunctive relief amounts to a litigation tactic “to jump the line on all other FOIA requesters—

including numerous other COVID-related requests—” when the gravamen of “[p]laintiff’s legal

1 Plaintiff initially requested an order compelling defendants’ response to the FOIA request at issue “on or before March 31, 2021,” Pl.’s Mot. at 1, but the parties subsequently proposed a briefing schedule for the requested injunctive relief proposing completion of briefing, after that date, by April 1, 2021, see Parties’ Joint Status Report, ECF No. 12, which proposed schedule was adopted by the Court, see Min. Order (Mar. 15, 2021).

1 claim is nothing more than a complaint that more than twenty days have passed since the

submission of the FOIA requests, for which the remedy is constructive exhaustion of

administrative remedies and the opportunity for court supervision of the processing and

production—not an order that Defendants immediately process and make productions ahead of

all other FOIA requests.” Defs.’ Opp’n to Pl.’s Mot. Preliminary Injunction (“Defs.’ Opp’n”) at

1, ECF No. 14. Defendants are correct and, for the reasons explained more fully below,

plaintiff’s motion is denied.

I. BACKGROUND

On December 24, 2020, plaintiff submitted identical FOIA requests to DHA and HHS

seeking expedited processing and production of four categories of data “from the Defense Health

Agency (‘DHA’),” regarding the federal government’s distribution of COVID-19 vaccines.

Defs.’ Opp’n, Ex. A, Decl. of Brandon Gaylord, HHS Freedom of Information/Privacy Act

Director (“Gaylord Decl.”), Ex. A (Dec. 24, 2020 Letter from Alexandra Settelmayer, NYT

Legal Dep’t, to HHS (“HHS FOIA Request”) at 15, ECF No. 14-1); id., Ex. B, Decl. of John

Boyer, DHA Freedom of Information/Privacy Act Manager (“Boyer Decl.”), Ex. A (Dec. 24,

2020 Letter from Alexandra Settelmayer, NYT Legal Dep’t, to DHA (“DHA FOIA Request”) at

9, ECF No. 14-2). 2 The requests seek a massive volume of “de-identified” data, broken down by

state, geographic zip code and/or county, about vaccination distribution, recipient demographics,

including race, ethnicity, age group and occupation, comorbidities, priority groups, usage and

waste, providers, manufacturers, and adverse reactions. Specifically, the requests seek DHA

records regarding:

[1.] Aggregate, de-identified data, broken down by zip code and county of the recipient, showing the number of individuals who have received one dose of a

2 Citations to exhibits to declarations use the pagination automatically assigned by the Court’s Case Management/Electronic Filing (CM/ECF) system.

2 coronavirus vaccine . . .[and the] aggregate, de-identified data, broken down by zip code and county of the recipient, showing the number of individuals who have been fully vaccinated . . that [is also] . . . [each] broken down by: [t]he race, ethnicity, and age group of vaccine recipients; [t]the comorbidities associated with vaccine recipients; [t]he Vaccination Priority Group (i.e. Phase 1a, Phase 1b) associated with the vaccine recipients; [t]he vaccine recipients’ status as a health care worker, long-term care facility resident, or member of any other priority group or profession; [t]he manufacture of the vaccine; and [t]he “administered location type” field entry (as defined by the CDC’s Covid-19 Vaccination Reporting Specification).

[2.] All available data showing the number of coronavirus vaccine doses that were allocated and distributed to each vaccine provider, broken down by state, county, and zip code.

[3.] All available de-identified data regarding allergic or adverse reactions to a coronavirus vaccine, including but not limited to the data tracked by the V-SAFE data system.

[4.] All available data showing the number of coronavirus vaccine doses that were distributed but not administered, including any records showing the reasons why those doses were not administered.

DHA FOIA Request at 9–10; HHS FOIA Request at 15–16.

Citing the “urgent demand to inform the public as to how [COVID-19] vaccines are being

distributed by the federal government,” “whether healthcare providers are administering

vaccinations in an equitable way,” DHA FOIA Request at 11, and to “facilitat[e] public trust in

the COVID-19 vaccines” by “helping the public to understand the number of vaccinations that

have been administered,” id. at 12, plaintiff requested expedited processing from both DHA and

HHS within “the ten . . . working day time limit set by law,” id. at 13 (citing 32 C.F.R. §

286.8(e)(1) and 5 U.S.C. § 552(a)(6)(E)(ii)(I)). 3

On January 26, 2021, DHA provided an “interim response” acknowledging receipt of

plaintiff’s FOIA request and granting a fee waiver, but denying the request for expedited

3 Given that the DHA Request and the HHS Request are identical, except for the recipient’s address block at the top of the request, only the DHA Request is cited.

3 processing because plaintiff had not demonstrated a “compelling need” for such processing.

Boyer Decl., Ex. B, Letter from DHA to Alexandra Settelmayer, NYT Legal Department (Jan.

26, 2021) (“DHA Response Letter”) at 16–17. DHA explained that plaintiff’s request was

placed in the “complex queue,” with an “estimated completion date [of] December 2021,” id. at

16, due to “unusual circumstances,” including “(a) the need to search for and collect records

from a facility geographically separated from [the] office; (b) the potential volume of records

responsive to [the] request; (c) the need for consultation with one or more agencies which have

substantial interest in either the determination or the subject matter of the records; and (d) an

unusually high volume of requests,” id.; see also Compl. ¶ 10. Noting the anticipated large

volume of data responsive to plaintiff’s request, DHA stated that the response “will require a

very lengthy search across the military health system,” and may require further processing

because the “[r]ecords sought may not be in the format and availability Plaintiff expects.” Boyer

Decl. ¶ 16.

On February 8, 2021, HHS also acknowledged receipt of plaintiff’s FOIA request and,

because the request “sought records from DHA, includes references to DHA throughout the

request and references DHA’s FOIA regulations,” Gaylord Decl. ¶ 8, HHS sought clarification

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kaimowitz v. Orlando, Florida
122 F.3d 41 (Eleventh Circuit, 1997)
De Beers Consolidated Mines, Ltd. v. United States
325 U.S. 212 (Supreme Court, 1945)
Sampson v. Murray
415 U.S. 61 (Supreme Court, 1974)
University of Texas v. Camenisch
451 U.S. 390 (Supreme Court, 1981)
Weinberger v. Romero-Barcelo
456 U.S. 305 (Supreme Court, 1982)
Amoco Production Co. v. Village of Gambell
480 U.S. 531 (Supreme Court, 1987)
Munaf v. Geren
553 U.S. 674 (Supreme Court, 2008)
Nken v. Holder
556 U.S. 418 (Supreme Court, 2009)
Cobell, Elouise v. Norton, Gale
391 F.3d 251 (D.C. Circuit, 2004)
Chaplaincy of Full Gospel Churches v. England
454 F.3d 290 (D.C. Circuit, 2006)
Davis v. Pension Benefit Guaranty Corp.
571 F.3d 1288 (D.C. Circuit, 2009)
Devose v. Herrington
42 F.3d 470 (Eighth Circuit, 1994)
Chester Kowalczyk v. Department of Justice
73 F.3d 386 (D.C. Circuit, 1996)
James Sherley v. Kathleen Sebelius
689 F.3d 776 (D.C. Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
New York Times Company v. Defense Health Agency, Counsel Stack Legal Research, https://law.counselstack.com/opinion/new-york-times-company-v-defense-health-agency-dcd-2021.